Synthesis and preliminary evaluation of 99mTc-Hynic-fragments [F(ab')2 and F(ab')] of Rituximab as radioimmunoscintigraphic agents for patients with Non-Hodgkin's lymphoma

Simple item page
dc.contributor.authorSuman, S. K.
dc.contributor.authorKameswaran, M.
dc.contributor.authorMallia, M.
dc.contributor.authorMittal, S.
dc.contributor.authorDash, A.
dc.date.accessioned2020-03-13T09:39:10Z
dc.date.available2020-03-13T09:39:10Z
dc.date.issued2019
dc.description.divisionRPhDen
dc.format.extent4108 bytes
dc.format.mimetypetext/html
dc.identifier.sourceApplied Radiation and Isotopes, 2019. Vol. 153: Article no. 108808en
dc.identifier.urihttp://hdl.handle.net/123456789/20439
dc.language.isoenen
dc.subjectNon-Hodgkin's lymphomaen
dc.subject99mTc-Hynic-F(ab')2-Rituximaben
dc.subject99mTc-Hynic-F(ab')-Rituximaben
dc.subjectRadioimmunoscintigraphic agenten
dc.titleSynthesis and preliminary evaluation of 99mTc-Hynic-fragments [F(ab')2 and F(ab')] of Rituximab as radioimmunoscintigraphic agents for patients with Non-Hodgkin's lymphomaen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0666.htm
Size:
4.01 KB
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2019